OXiGENE Reports Full Year 2011 Financial Results
SOUTH SAN FRANCISCO, Calif., March 13, 2012 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGND), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the year ending December 31, 2011.